Thematic overview of symposia

Take a first look at the list of the accepted symposia, grouped by scientific topics

Psychopathology

  • Social interaction deficits in psychosis – neural correlates and potential treatments
  • Using the COVID-19 context to improve our understanding of the development and maintenance of mistrust and paranoid delusions
  • Assessment and treatment of schizophrenia negative symptoms
  • Mechanisms of amotivation in the psychosis spectrum

Early recognition and prediction of psychosis

  • Detection and treatment of psychosis transition
  • E-Mental health for psychosis: Implications for detection, monitoring and treatment
  • Precision psychiatry for early psychosis: A symposium outlining multilevel stratification methods and results
  • National networks for the prevention of psychoses – achievements and challenges

Diagnosis and Classification/comorbidity

  • From one to many: A splitters’ account of psychomotor phenotypes in endogenous psychoses
  • The challenging diagnosis of autoimmune psychosis
  • Dissociative and psychotic disorders: Overlap and differences in symptoms
  • Toward a better understanding of catatonia: An historical, epistemological and system neuroscience approach

Treatment

  • Moving towards recovery: The role of an active lifestyle in improving the health and functioning of people with severe mental illness
  • Lifestyle interventions for the treatment of individuals with psychotic disorders
  • User involvement in mental health in South-Eastern Europe
  • New Perspectives in Schizophrenia Diagnosis, Treatment, and Care

outcome

  • The influence of childhood interpersonal trauma on premorbid adjustment, social cognition and outcome in psychosis

Health Services Research

  • Mental health treatment for individuals with psychosis in South-Eastern Europe – challenges and new developments

Neurobiology

  • Genes to brains: Understanding schizophrenia by integrating gene expression and neuroimaging data
  • The European Consensus on sensorimotor abnormalities in psychosis – impact, assessment and treatment recommendations
  • Sensorimotor system dysfunction in schizophrenia and related disorders
  • How to approach catatonia in 2021

Neuroimaging

  • Using M/EEG paradigms, dynamic causal modelling and pharmacological manipulations to investigate altered brain computations in schizophrenia
  • Changes in glutamatergic neurotransmission and its significance in psychosis - evidence from 1-HMRS studies
  • Reward system dysfunction across the psychosis spectrum
  • Neuroimaging psychopathology in schizophrenia

Neuropsychology

  • Learning under uncertainty in different stages of psychosis

Psychophysiology

  • Translational electrophysiology in schizophrenia: Relevance for circuits mechanisms, symptoms and biomarkers
  • Advances on the electrophysiological biomarkers and biotyping for diagnosis and prognosis in psychosis
One topic we will certainly be discussing is:

Should Schizoaffective Disorder be Diagnosed Cross-Sectionally (ICD-11) Instead of Longitudinally (DSM-5)? 

Once the invited experts have confirmed their participation, we will announce the respective core sessions!